Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38,118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial.
Lu S, Pan H, Wu L, Yao Y, He J, Wang Y, Wang X, Fang Y, Zhou Z, Wang X, Cai X, Yu Y, Ma Z, Min X, Yang Z, Cao L, Yang H, Shu Y, Zhuang W, Cang S, Fang J, Li K, Yu Z, Cui J, Zhang Y, Li M, Wen X, Zhang J, Li W, Shi J, Xu X, Zhong D, Wang T, Zhu J. Lu S, et al. Among authors: yu y, yu z. Signal Transduct Target Ther. 2023 Jun 30;8(1):249. doi: 10.1038/s41392-023-01454-z. Signal Transduct Target Ther. 2023. PMID: 37385995 Free PMC article. Clinical Trial.
Informatics on Drug Repurposing for Breast Cancer.
Zhou H, Liu H, Yu Y, Yuan X, Xiao L. Zhou H, et al. Among authors: yu y. Drug Des Devel Ther. 2023 Jun 28;17:1933-1943. doi: 10.2147/DDDT.S417563. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37405253 Free PMC article. Review.
[Clinical characteristics of osteopetrosis in 4 children].
Deng X, Yin F, Yu Y, Peng J. Deng X, et al. Among authors: yu y. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Jun;36(6):581-4. doi: 10.3969/j.issn.1672-7347.2011.06.018. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21743153 Chinese.
Novel Quantitative Contrast Sensitivity Function Enhances the Prediction of Treatment Outcome and Recurrence in Amblyopia.
Liu J, Huang C, Cotter SA, Chan LYL, Yu Y, Jia Y, Ye Q, Feng L, Yao Y, Jiang R, Xiao C, Xu Z, Zhuang Y, He Y, Zhou Y, Chen X, Yuan J, Wen Y, Yu W, Pang Y, Lu ZL, Thompson B, Li J. Liu J, et al. Among authors: yu y. Invest Ophthalmol Vis Sci. 2024 May 1;65(5):31. doi: 10.1167/iovs.65.5.31. Invest Ophthalmol Vis Sci. 2024. PMID: 38771572
38,118 results
You have reached the last available page of results. Please see the User Guide for more information.